Intravenous Cardioversion of Atrial Fibrillation (AF) With AZD1305

NCT00915356 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

228

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: AZD1305
DRUG: Placebo

Sponsor

AstraZeneca